AtkinsRéalis Group (ATRL) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
28 Apr, 2026Executive summary
Achieved record revenue and Segment Adjusted EBIT in 2024, driven by strong demand in nuclear and engineering services, with a record backlog as of December 31, 2024.
Announced sale of entire 6.76% interest in Highway 407 for ~$2.8 billion, a key step in strategic simplification and value creation.
Successfully concluded the "Pivoting to Growth" strategy, meeting or exceeding all 2024 targets, and launched a new phase focused on excellence and growth for 2025-2027.
Major contract wins in nuclear, including the first CANDU® new build since 2007 and significant life extension projects in Romania and Canada.
Positive net cash from operating activities and reduced leverage, with a leverage ratio of 1.1x at year-end.
Financial highlights
Total 2024 revenues rose 12% year-over-year to $9.7 billion; services revenue up 16%.
Segment-adjusted EBIT rose 10% to $845 million; adjusted net income from PSMPM up 15% to $315 million.
Net cash from operating activities was $526 million, a significant increase from $66 million in 2023.
IFRS net income from continuing operations was $284 million, with diluted EPS of $1.62.
Backlog reached a record $17.5 billion, up 24-25% year-over-year.
Outlook and guidance
2025 organic revenue growth for engineering services regions expected at 7-9%, with segment-adjusted EBITDA margin of 16-17%.
Nuclear segment revenue guidance for 2025 is $1.6-$1.7 billion, with adjusted EBIT margin of 12-14%.
Operating cash flow for 2025 expected to exceed $300 million, with CapEx of $150-$200 million focused on Monarch nuclear reactor development.
2025-2027 targets include >8% organic revenue CAGR for Engineering Services Regions and 17-18% EBITDA margin by 2027.
Latest events from AtkinsRéalis Group
- Record revenue, backlog, and nuclear growth highlight a transformative Q2 with major asset sale.ATRL
Q2 202528 Apr 2026 - Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 20257 Apr 2026 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 20243 Feb 2026 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight Q2 2024.ATRL
Q2 20241 Feb 2026 - Q3 2024 delivered record Nuclear backlog, margin gains, and robust cash flow generation.ATRL
Q3 202414 Jan 2026 - Record backlog and surging Nuclear growth drive raised outlook and strong Q1 2025 results.ATRL
Q1 202519 Nov 2025 - Q3 2025 saw double-digit revenue and EPS growth, record backlog, and raised Nuclear guidance.ATRL
Q3 202513 Nov 2025